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Abstract In the embryo, organs gradually take shape as tissue progenitors, proli-
ferate, differentiate and are organised, via cellular interactions, in tri-dimensional
functional structures. Most adult organs retain a cell population sharing important
similarities with embryonic progenitors, which includes the ability to both self-
renew and to differentiate into the full range of the specialised cell types corres-
ponding to the organ in which they reside. These two essential properties define
them as adult stem cells (AdSC). Their characterization in different contexts pro-
vides a better understanding of cell turnover modalities for organ function, which is
important for tumorigenesis, because adult tissue stem cells can give rise to cancer
stem cells. However, it is also relevant to regenerative medicine, because stem cells
can be transplanted or manipulated in vivo to restore missing cells. The successful
reprogramming of somatic cells into induced pluripotent stem cells (iPSC)
(Takahashi and Yamanaka, Cell 126:663–676, 2006), resembling pluripotent
embryonic stem cells (ESC), opened alternative strategies for cell replacement.
The required cell type can be differentiated in vitro from expandable progenitors
and transplanted where required. This approach is particularly promising, because
genetic defects can potentially be repaired in vitro prior to their engraftment;
moreover, a large number of cells can be produced (Fox et al., Science
345:1247391, 2014). However, the transplanted cells have to be able to functionally
integrate into the deficient organ. To potentially alleviate this problem,
tri-dimensional culture systems have been recently developed where mini-organs,
or organoids, can be obtained in vitro. These also represent unique models for
disease modelling and drug screening (Huch and Koo, Development
142:3113–3125, 2015). Within neuroendocrine systems, the hypothalamo-pituitary
axis has a crucial role for body homeostasis. It also regulates functions such as
growth, reproduction, stress and, more generally, metabolism. The hypothalamus
centralizes information from the periphery and other brain regions to regulate
pituitary hormone secretions and to control appetite, sleep and aging. Its functions
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are exerted through secretion of neurohormones and manipulation of these could be
of interest not only for the treatment of obesity and sleep disorders but also to
alleviate aging-related conditions. Pituitary hormone deficiencies can originate
from defects affecting the hypothalamus, pituitary, or both. Today these defi-
ciencies are treated by substitution or replacement therapies, which are costly and
have side effects. AdSC have recently been characterized in the hypothalamus and
pituitary (Castinetti et al., Endocr Rev 32:453–471, 2011; Bolborea and Dale,
Trends Neurosci 36:91–100, 2013). Moreover, hypothalamic neurons and pituitary
endocrine cells have been differentiated in vitro from ESC and iPSC and success-
fully transplanted. These promising routes for development of regenerative medi-
cine to restore or manipulate the function of the hypothalamo-pituitary axis will be
discussed here, and further challenges considered.
Introduction
It is now clear that multipotency, once thought to be largely restricted to embryonic
stages and to a few stem cell types in the adult, is preserved postnatally, as most
adult tissues comprise a population of undifferentiated cells. These are character-
ized by their ability to undergo asymmetric divisions, underlying self-renewal and
an ability to have differentiated cell progeny, the two essential properties of stem
cells. Pluripotency, the ability to produce all adult cell types, can be “recovered”
in vitro by reprogramming somatic cells into induced pluripotent stem cells (iPSC;
Takahashi and Yamanaka 2006). In addition, transdifferentiation to another cell
type or to multipotency can be forced onto differentiated cell types by activating
expression of specific factors or via cell fate conversion with chemicals and/or
growth factors (Vierbuchen and Wernig 2012). While these discoveries are by
themselves challenging our view of cellular plasticity and its limits, for medicine
they mean that therapies can progress from or incorporate both a pharmacological
approach and a cellular one, where abnormal, deficient or entirely missing cells can
be replaced (Fox et al. 2014). Cellular reprogramming implies, in particular, the
possibility of autologous transplantation, alleviating at least some aspects of
immune rejection that, in conjunction with genome editing tools (Hsu
et al. 2014), hold great promise for deriving, repairing, differentiating and
transplanting back functional, patient-specific cells. In addition, the derivation of
patient-specific cells by itself represents a great advance toward in vitro disease
modelling and drug screening (van de Wetering et al. 2015). In the clinic, some
promising results have already been obtained in pilot studies using retinal pigment
cells derived from human ESC (Schwartz et al. 2015), but other trials have also
highlighted the many challenges to be overcome (Steinbeck and Studer 2015). It is
likely that further development of three-dimensional (3D) organoids (Huch and
Koo 2015) and tissue engineering, combining several different cell types for
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formation of vascularized mini-organs, will greatly enhance transplantation effi-
ciency and functional repair (Shamir and Ewald 2014). Finally, another important
aspect to consider for use of these therapies is the financial one. Numerous quali-
tative criteria have to be satisfied to allow clinical use of stem cells. Currently, and
for good reasons, these criteria have to be stringent (French et al. 2015) and
therefore expensive. Although experience, scaling up, and automation might lead
to a relaxation of requirements and to reduced costs, we still need to question today
how feasible it will be to routinely offer such treatments in the future. It would be
unfair if treatments were only available to the very privileged few.
We will focus our attention here on stem cells of the hypothalamo-pituitary axis,
and why and how these could be used for regenerative medicine. The hypothalamo-
pituitary axis, while a crucial regulator of homeostasis, also ensures that the
organism responds appropriately to changing physiological situations such as
puberty, pregnancy, lactation, and stress. While many hypothalamic roles are exe-
cuted through the pituitary, with the seven different hormones secreted by the gland
affecting most physiological processes, some hypothalamic neurons also directly
interact with other regions of the brain to control appetite (Schneeberger
et al. 2014), sleep and wakefulness (Konadhode et al. 2014). Finally, it has recently
been proposed that systemic aging is initiated in the hypothalamus (Zhang
et al. 2013). Consequently, pathological situations leading to hypothalamic and/or
pituitary hormone imbalance have pleiotropic consequences, resulting in significant
morbidity and even mortality. These can be congenital or acquired and originate
from a defective pituitary, hypothalamus or both; moreover, in most cases they are
of unknown aetiology (Kelberman et al. 2009). The most frequent congenital defect
is isolated growth hormone deficiency, with a prevalence of 1 in 3500–10,000 births
(Kelberman et al. 2009). Later in life, acquired deficits develop mainly as a conse-
quence of pituitary tumors, mostly affecting lactotrophs, or from brain damage
(Hannon et al. 2013). Hormone substitution or replacement therapies are available
to treat pituitary deficiencies. However, these are not optimal, first because they do
not reproduce normal physiological secretion patterns, secondly because they are
associated with side effects (Alatzoglou et al. 2014), and thirdly, they are not
inexpensive; hGH treatment in the UK costs up to £12,000/year for children in
whom treatments can last for several years. Being able to provide secreting endo-
crine cells would, therefore, represent a significant advance, particularly for pedi-
atric patients where the pituitary is primarily affected but perhaps also for those
where an hypothalamic deficiency is thought to be responsible, such as Prader-Willi
syndrome, or more generally where a hypothalamic defect leads to formation of
an underdeveloped pituitary gland (Rizzoti et al. 2004). Pituitary hormones can,
in turn, also feed back on the formation of hypothalamic neuronal circuitry
(Sadagurski et al. 2015); therefore, they may be able to improve some hypothalamic
defects. Manipulating or restoring hypothalamic function would be beneficial in
cases of infertility and obesity, which has already been shown using cell or tissue
transplants (see below), but also for sleep disorders; importantly, it might lighten
some age-associated conditions.
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In this perspective we will first briefly describe the morphogenesis of the ventral
diencephalon, from which the hypothalamus derives, and of Rathke’s pouch (RP),
the pituitary anlagen. The transition between tissue progenitor and stem cell pheno-
type will then be discussed in the context of the developing pituitary. Recently,
populations of AdSCs have been described and partially characterized in both
compartments of the axis (Lee et al. 2012; Li et al. 2012; Andoniadou et al. 2013;
Haan et al. 2013; Rizzoti et al. 2013; Robins et al. 2013a, b; Castinetti et al. 2011)
and their characterization will be presented here, with reference to other chapters of
this book. Finally, exciting progress has been made toward the use of stem cells for
regenerative medicine in the axis: both hypothalamic neurons (Wataya et al. 2008;
Merkle et al. 2015; Wang et al. 2015) and pituitary endocrine cells (Suga
et al. 2011; Dincer et al. 2013) have been obtained in vitro from stem cells and
successfully transplanted in mice. We will discuss these reports and the future
challenges toward clinical use of stem cells in the hypothalamo-pituitary axis.
Morphogenesis of the Hypothalamo-Pituitary Axis (Fig. 1)
Hypothalamus
In the embryo, the hypothalamus develops from the ventral diencephalon. During
the specification of the neural plate, at 8 days post-coitum (dpc) in mice, the pros-
pective ventral diencephalon is situated at the midline, in the rostral-most position.
It is in contact with the future pituitary, which is present as the hypophyseal placode
at this stage, in the adjacent ectoderm at the anterior neural ridge (see below). As the
neural plate bends to close (McShane et al. 2015), increased proliferation of the
telencephalic progenitors versus those in the ventral diencephalon causes an appar-
ent posterior shift of the prospective hypothalamus, located ventrally and posterior
to the telencephalic vesicles in 9.5-dpc mouse embryos. A localized evagination of
the ventral diencephalon toward the underlying developing pituitary becomes
apparent at 9.5 dpc. From this particular region, called the infundibulum, the
median eminence (ME), pituitary stalk and pituitary posterior lobe will develop.
The ME, located at the floor of the third ventricle, is a circumventricular organ,
which means that the blood-brain barrier is interrupted at its level. Hypothalamic
neuro-hormones collect here into a bed of fenestred capillaries belonging to the
hypohyseal portal system, which then transport them to the pituitary. Within the
ME, special glial cells, the tanycytes, regulate neurohormone secretion at the axon
termini levels (Prevot et al. 2010). These also integrate peripheral information by,
for example, sensing glucose concentration and responding to thyroid hormone
(Bolborea and Dale 2013; Ebling 2015). Moreover, and importantly, at least a
proportion of tanycytes have been shown to comprise hypothalamic stem cells
(see below). These cells therefore perform crucial regulatory roles at this blood-
brain interface in the short term, by regulating neurohormone secretion, but also in
the long term, by modulating hypothalamic cell numbers. Some hypothalamic
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neurons, namely those secreting oxytocin and vasopressin, reach directly into the
posterior lobe of the pituitary; their axons, along with the portal system capillaries,
are located within the pituitary stalk. Pituicytes, glial cells present both in the stalk
and posterior pituitary, are proposed to regulate neurosecretion at these levels.
Tanycytes and pituicytes both originate from the infundibulum, and no neurons
are produced in this domain (Goto et al. 2015). The specification of the infundi-
bulum in the embryo is complex and relies on an antagonism between members of
the bone morphogenetic protein (BMP) family, present in the future infundibulum,
and the secreted molecule Sonic Hedgehog (SHH), which is excluded from it (Zhao
et al. 2012; Trowe et al. 2013). Members of the fibroblast growth factor (FGF)
family are in turn required for infundibular cell expansion (Pearson et al. 2011). The
transcription factor LHX2 is necessary for formation of the infundibulum in the
embryo and later on for expression of the RAX transcription factor, which is
essential for ventro-medial hypothalamic development (Lu et al. 2013) and the
emergence of tanycytes (Salvatierra et al. 2014). The NOTCH pathway is also
required for correct morphogenesis of this region (Goto et al. 2015), but it is unclear
at present how these different signalling pathways are integrated.
Fig. 1 Development and function of the murine pituitary-hypothalamic axis. Rostral to the
presumptive hypothalamus, pituitary development is initiated with the appearance of the hypo-
physeal placode at 8.5 dpc in the mouse. At 9.5 dpc, the placode invaginates to become the
Rathke’s pouch (RP). Within the diencephalon, the infundibulum evaginates towards RP by 10.5
dpc. It will give rise to the median eminence (ME), the pituitary stalk and the posterior lobe,
whereas the anterior and intermediate lobes originate from RP. Gradually, hypothalamic neurons
forming the different nuclei differentiate. Postnatally, the hypothalamus centralizes peripheral
information and controls, through release of hypophysiotropic hormones, pituitary endocrine
secretions. Hypothalamic peptide hormones can reach the gland directly, such as oxytocin and
vasopressin secreted directly in the posterior lobe, or via the hypophyseal portal system. Hypo-
thalamic neuropeptides (GnRH, gonadotrophin releasing hormone, GHRH GH releasing hormone,
TRH TSH releasing hormone, CRH corticotropin releasing hormone and the inhibitory SST,
somatostatin) are secreted at the ME and collected by capillaries. Anterior pituitary endocrine
cells comprise lactotrophs (producing prolactin, Prl), gonadotrophs (producing luteinizing hor-
mone, LH, and follicle stimulating hormone, FSH), thyrotrophs (producing thyroid stimulating
hormone, TSH), corticotrophs (producing adenocorticotropic hormone, ACTH, proteolytically
cleaved from proopiomelanocortin, POMC) and somatotrophs (producing growth hormone,
GH). Adapted from Rizzoti (2015)
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As neurogenesis takes place, hypothalamic neurons differentiate and migrate to
form groups of neurons, or nuclei. Nuclei located the furthest away from the third
ventricle are formed first, whereas the latest to differentiate are closest. The GnRH
neurons are the only exception, as these originate from the olfactory placode and
migrate through the developing brain to reach their destination around the ME,
where they control reproductive function (Stevenson et al. 2013) and aging (Zhang
et al. 2013). Each nucleus regulates different physiological functions, such as
circadian rhythms by the supra-chiasmatic nucleus or feeding behaviour by the
arcuate. Hypothalamic morphogenesis is complex because of its organization,
which lacks clear morphological landmarks; this explains why we know compar-
atively less about it compared to other regions of the brain where the anatomy is
somehow simpler. Mechanisms of hypothalamic neurogenesis are beyond the scope
of this perspective and have been recently comprehensively reviewed (Bedont
et al. 2015; Pearson and Placzek 2013).
Pituitary
The first sign of pituitary development is the appearance at 8 dpc of an ectodermal
thickening in the rostral-most position, in the anterior neural ridge just in front of
the future ventral diencephalon. This domain, the hypophyseal placode, forms
along with the olfactory, optic and otic placodes (Soukup et al. 2013; Schlosser
et al. 2014). As the presumptive diencephalon is apparently shifted posteriorly at
9.5 dpc, the hypophyseal placode is present just underneath and has become the
pituitary anlagen or RP. RP is an epithelial invagination that forms in continuity
with the oral ectoderm and extends dorsally toward the ventral diencephalon. RP is
also in contact with the anterior border of foregut endoderm (Khonsari et al. 2013),
and both dorsally and ventrally secreted signals are crucial for proper RP morpho-
genesis. SHH, independently of its role for formation of the infundibulum, is
required for RP development, but it is not expressed in the pouch (Wang
et al. 2010). The infundibulum is crucial for induction and maintenance of the
pouch at these early stages, predominantly through secretion of BMP and FGF
signals, respectively (Ericson et al. 1998; Treier et al. 1998). RP grows rapidly and
by 11.5 dpc it also separates from the oral ectoderm. The three pituitary lobes do not
have the same embryonic origin because anterior and intermediate lobes are RP
derivatives, whereas the posterior one has a neurectodermal origin.
As development progresses, the main wave of cell cycle exit in the developing
pituitary, correlating with endocrine cell commitment and differentiation, occurs
between 11.5 and 13.5 dpc (Japon et al. 1994; Davis et al. 2011). As cells exit the
cell cycle, they adopt more ventral and lateral locations and loose epithelial
characteristics, reminiscent of epithelial to mesenchymal transition (Himes and
Raetzman 2009). Endocrine cells then gradually organize in homotypic endocrine
networks, resulting in more efficient and coordinated hormonal secretion in the
adult (Mollard et al. 2012). Pituitary cell fate specification is also discussed in
Drouin (2016).
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In rodents, the gland will undergo a phase of important growth during the first
weeks of life. This is characterized by high levels of proliferation, both in pro-
genitors and in endocrine cells. Endocrine cells retain the capability to proliferate
throughout life, but they do so rarely (Levy 2002). After birth, the hypothalamus
will take control of pituitary endocrine maturation, secretions, and perhaps also
stem cell homeostasis, but it is not clear exactly when and how its influence starts to
be exerted.
Transition Between Tissue Progenitor and Stem Cell Phenotype
in the Developing Pituitary
Early RP progenitors express the transcription factor SOX2 (Fauquier et al. 2008),
and lineage-tracing experiments using a Sox2creERT2 allele have shown that SOX2-
positive progenitors give rise to all endocrine cell types in the pituitary
(Andoniadou et al. 2013; Rizzoti et al. 2013). In addition, embryonic progenitors
give rise to adult pituitary stem cells (Rizzoti et al. 2013). From 14.5 dpc and
towards the end of gestation in the mouse, SOX9 is upregulated in the pituitary,
exclusively in SOX2-positive cells. Both proteins will remain co-expressed post-
natally in pituitary stem cells (Fauquier et al. 2008; Rizzoti et al. 2013). While
SOX2 and SOX9 belong to the same group of transcriptional regulators, sequence
homology assigns them to different sub-families (SOXB1 and SOXE, respectively);
they therefore have different partners, target genes and hence, roles (Kamachi and
Kondoh 2013). SOX9 is required for maintenance of different ectodermal stem cell
populations, such as hair, retinal, neural crest, and neural stem cells (NSC) (Sarkar
and Hochedlinger 2013). In the developing neuroepithelium, SOX9 is both required
and sufficient for formation of multipotent NSC, seemingly given them the ability
to give rise to glial cell types and not just neurons (Scott et al. 2010). In the adult,
the protein is involved in the maintenance of NSC and their multipotentiality (Scott
et al. 2010).
In the developing pituitary, we observe that up-regulation of SOX9 correlates with
a decreased proliferative potential in pituitary progenitors, with the percentage of
SOX2-positive proliferating cells reduced by a factor of two between 12.5 and 16.5
dpc (Fig. 2). In addition, lineage-tracing experiments, using either a Sox9ires-creERT2
allele or the Sox2creERT2 allele, but where it is induced coincident with the upregulation
of SOX9 in pituitary progenitors, show that the SOX9;SOX2-positive progenitors also
tend to differentiate less often (Rizzoti et al. 2013). Therefore, the expression of SOX9
correlates both with reduced levels of proliferation and differentiation, two character-
istics of pituitary stem cells that distinguish them from embryonic progenitors. So far,
deletion of the gene during pituitary development has not revealed a significant role
for SOX9 in the gland before birth (unpublished data); therefore, its function in
pituitary progenitors does not parallel what is observed in the developing CNS.
Further investigations are now required to examine its function postnatally. Analysis
of its target genes may be informative to characterise the transition between tissue
progenitor and stem cell phenotypes.
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Characterization of AdSC in the Hypothalamo-Pituitary Axis
(Fig. 3)
Hypothalamus
Initial investigations of cell proliferation patterns in the post-natal hypothalamus
revealed the presence of dividing cells, in particular around the third ventricle, just
above the ME. Cell proliferation could be stimulated by infusion of different
factors, such as BDNF (Pencea et al. 2001), EFG and FGF (Xu et al. 2005), IGF
(Perez-Martin et al. 2010) and CNTF (Kokoeva et al. 2005). In addition, label-
retaining experiments suggested active neurogenesis in the hypothalamus
(Kokoeva et al. 2005, 2007; Xu et al. 2005; Perez-Martin et al. 2010), defining a
Fig. 2 Rate of proliferation of pituitary embryonic progenitors before and after SOX9
up-regulation. (a) Assessment of proliferative rates by incorporation of EdU at 12.5 and
16.5dpc. Immunofluorescence for SOX2 (green) and EdU-labelling (red) after 1 h00 EdU pulse.
At 12.5dpc all cells express SOX2 and a high proportion is dividing. At 16.5dpc, progenitors/stem
cells are dorsally restricted to cells lining the cleft and proliferation is significantly reduced. (b)
Quantification of EdU incorporation. At 12.5 dpc, 40.5% (SD¼ 7.5 n¼ 6) of SOX2þve cells in RP
have incorporated EdU, whereas at 16.5 dpc, as SOX9 is up-regulated, only 19.2% (SD¼ 2.1,
n¼ 6) do so (asterisks in b?)
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Fig. 3 Regenerative medicine in the hypothalamo-pituitary axis: endogenous stem cells and
in vitro differentiated cell types. Endogenous stem cell (SC) populations (red) and differentiated
progeny (brown) obtained in vitro are represented. In the hypothalamus, tanycytes, specialized
glial cells located at the base of the third ventricle, form a diet-responsive stem cell population. In
the pituitary, stem cells are present in the epithelium lining the cleft and are also scattered in the
anterior lobe, sometimes as rosettes. Both hypothalamic neurons and pituitary endocrine cells have
been obtained in vitro from ESC and iPSC. In the hypothalamus, transplantation of neurons could
be used to modulate feeding behaviour to treat obesity for example, but the range of neurons
obtained in vitro could potentially be used to manipulate a range of hypothalamic functions. In the
pituitary, transplantation of endocrine cells would represent a significant improvement over
existing replacement or substitution therapies
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third neurogenic niche in the brain along with the sub-ventricular zone of the lateral
ventricles and the dentate gyrus of the hippocampus. Kokoeva et al. (2005) were the
first to suggest that hypothalamic neurogenesis was physiologically relevant, as
they demonstrated a role for newly generated neurons in feeding control. More
recently, lineage tracing experiments have firmly established the existence of active
hypothalamic neurogenesis and gliogenesis (Lee et al. 2012; Li et al. 2012; Haan
et al. 2013; Robins et al. 2013a, b; see also Blackshaw 2016) Precise dissections of
the third ventricle sub-ventricular zone revealed that α-tanycytes are hypothalamic
AdSC (Robins et al. 2013b); this area is also where cell proliferation is most
efficiently stimulated by IGF infusion (Perez-Martin et al. 2010). WNT signalling
appears to regulate tanycyte generation post-natally (Wang et al. 2012). In addition,
it has been suggested that some stem cells may reside in the parenchyma (Robins
et al. 2013a). Following the initial report by Kokoeva et al., investigations have
mostly focused on the role of hypothalamic neurogenesis in feeding control (Lee
et al. 2012; Li et al. 2012; McNay et al. 2012; Haan et al. 2013). Stem cells are
responsive to diet and a high fat diet reproducibly impairs neurogenesis in the
arcuate nucleus (Li et al. 2012; McNay et al. 2012; Lee et al. 2014). Further results
strengthen the association between pathological weight gain and neurogenesis
impairment. Leptin is a satiety hormone, secreted by adipose cells and transported
to the hypothalamus where it participates in appetite regulation. Obesity is associ-
ated with leptin insensitivity and, interestingly, leptin deficiency in mice results in
impaired neurogenesis (McNay et al. 2012). Moreover, it has been known for some
time that obesity is associated with hypothalamic inflammation. As this inflamma-
tion precedes obesity onset, it is increasingly suspected to be the cause, rather than
the consequence, of diet-induced metabolic disease (Valdearcos et al. 2015). The
association of high fat diet, leptin deficiency and hypothalamic inflammation with
impaired neurogenesis (Li et al. 2012; McNay et al. 2012) further highlights the
importance of neurogenesis in feeding control, all suggesting that manipulation of
this process may have therapeutic benefits for metabolic syndromes.
In addition to feeding control, studies in seasonal mammals support a role for
hypothalamic neurogenesis in the control of reproduction (Batailler et al. 2015;
Ebling 2015). Moreover, there is now evidence that systemic aging is initiated by
hypothalamic inflammation (Zhang et al. 2013). The relevant targets of this inflam-
mation, initiated by microglia, are the GnRH neurons, causing them to secrete less
GnRH. The authors show that this decrease in GnRH contributes to systemic aging
and that it is associated with decreased neurogenesis in both the hypothalamus and
hippocampus. Its contribution to these processes is so far unclear, but GnRH
administration rescues both GnRH levels and neurogenesis, demonstrating at
least a correlation (Zhang et al. 2013). It would now be of interest to investigate
the contribution of hypothalamic SC in other life-changing, physiological contexts,
such as puberty and pregnancy, where the organism needs to adapt to and trigger,
in the case of puberty, a new physiological status.
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Pituitary
In the adult gland, the persistence of an epithelial cell layer lining the pituitary cleft
(the remnant of the embryonic RP epithelium surrounding the lumen), and the
maintenance of SOX2 and SOX9 expression in this epithelial cell layer, was a good
argument for the persistence of a progenitor population (Fauquier et al. 2008).
The capacity of these cells to form spheres or colonies in vitro, an assay used to
characterize progenitors in different tissues further reinforced this hypothesis (Chen
et al. 2005; Lepore et al. 2005; Fauquier et al. 2008). Recently, lineage tracing
analysis using either Sox2 or Sox9CreERT2 targeted alleles definitively demonstrated
their presence in the adult (Andoniadou et al. 2013; Rizzoti et al. 2013; see also
Vankelecom 2016).
Under normal physiological conditions, adult pituitary stem cells proliferate and
differentiate very little, suggesting that most cell turnover is due to endocrine cell
division (Fauquier et al. 2008; Andoniadou et al. 2013; Rizzoti et al. 2013). Induc-
tion of apoptosis upon cell division, using specific genetic tools, confirmed this
hypothesis by demonstrating that corticotroph turnover relies on the proliferation of
differentiated cells (Langlais et al. 2013). A physiological role for pituitary stem
cells was initially suggested by studies investigating models of pituitary target
organ ablation (Nolan and Levy 2006). It has been known for some time that
ablation of the adrenals and/or gonads triggered a transient mitotic wave in the
gland, followed by generation of increased numbers of endocrine cells; moreover,
these were specifically the type that normally regulates the ablated organ. While
differentiated endocrine cells can divide, but do so rarely, Nolan and Levy were the
first to observe that, after adrenalectomy and/or gonadectomy, proliferation is
essentially restricted to non-endocrine cells of an immature appearance. Moreover,
double ablations do not have an additive proliferative effect, suggesting that a
single population of undifferentiated cells responds to both adrenalectomy and
gonadectomy (Nolan and Levy 2006). More recently, diphtheria toxin-mediated
endocrine cell ablation experiments confirmed these results by showing a mobili-
zation of SOX2-positive cells, with a transient induction of proliferation and,
presumably, differentiation. The extent of endocrine cell regeneration was limited
and initial endocrine cell numbers never fully recovered; however, this could
indicate that a partial recovery is physiologically sufficient (Fu et al. 2012; Fu
and Vankelecom 2012). Finally, lineage-tracing experiments performed after pitui-
tary target organ ablation firmly demonstrated that AdSCs both proliferate and
differentiate, exclusively to give rise to the required cell type, such as corticotrophs
(Rizzoti et al. 2013). This finding definitively established the regenerative potential
of pituitary stem cells but also showed that they seem to be mostly, and perhaps
only, mobilized under physiological challenge. Dissection of the mechanisms
underlying mobilization is now required to investigate whether it would be possible
to directly stimulate stem cells for therapeutic purposes. Further investigation into
different, more physiological “challenging” situations such as, for example,
Perspective on Stem Cells in Developmental Biology, with Special Reference. . . 145
pregnancy and lactation will also be necessary to fully explore potential roles for
AdSCs.
While stem cells appear quiescent under normal physiological situations, their
proliferation or at least activation may also be involved in tumorigenesis. The WNT
signalling pathway is an important regulator of embryonic development but also of
many AdSC populations (see Andoniadou 2016). Moreover, deregulation of the
pathway is associated with cancer formation, a notable example being colorectal
tumors (Clevers and Nusse 2012). In mice, it had been shown that expression of a
degradation-resistant form of βcatenin, an important transducer of WNT signalling,
in RP induced the formation of tumors resembling the mostly pediatric pituitary
craniopharyngiomas (Gaston-Massuet et al. 2011). Postnatal induction of this
constitutively active form of βcatenin in SOX2-positive cells also resulted in
tumor formation, demonstrating the tumor-forming potential of the AdSC compart-
ment. Tumors were, however, not composed of mutant stem cells, which instead
induced neighboring cells to form them by a paracrine mechanism (Andoniadou
et al. 2013). In resected human pituitary adenomas, a side population could be
isolated. SOX2 expression was upregulated and spheres could be formed,
suggesting the presence of a SOX2-positive progenitor population in tumors
(Mertens et al. 2015). However, the role of SOX2-positive cells in adenoma
formation is at present unclear.
In vitro Recapitulation of Ontogenesis in the Hypothalamo-
Pituitary Axis (Fig. 3)
Two different methods have mostly been used to direct ESC differentiation towards
differentiated cell types: tri-dimensional floating aggregates with relatively mini-
mal exogenous treatments, where cell interactions underlie self-patterning into a
defined embryonic structure with spectacular results, such as formation of an
optic cup realized in the lab of the late Yoshiki Sasai (Eiraku et al. 2011); and
two-dimensional cultures where sequential exogenous treatments guide cells
through subsequent embryonic fates. Both methods have been successfully used
to reproduce the embryonic events described above and obtain both human and
murine neuroendocrine and endocrine cells.
Induction of Hypothalamic Identity from 3D ESC Aggregates
Mouse ESC aggregates were initially assayed for hypothalamic neuron generation
(Ohyama et al. 2005). Neural progenitor fate was first induced under serum-free
conditions (Okabe et al. 1996), followed by SHH and BMP7 treatment that resulted
in the generation of ventral hypothalamic neurons (Ohyama et al. 2005). In a later
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study, culture under strictly defined chemical conditions to minimize exogenous
signals was shown to be key to obtain rostral-most hypothalamic character in mouse
ESC aggregates, which adopt an embryonic neuroepithelium-like morphology
because neural anterior fate is acquired by default in such conditions (Wataya
et al. 2008). Removal of insulin was crucial as it was shown to activate the Akt
pathway, which would otherwise inhibit hypothalamic induction. Further treatment
with SHH induces rostro-ventral hypothalamic identity, with a strong expression of
RAX. Selection and re-aggregation of RAX positive cells, without SHH addition,
resulted in the differentiation of morphologically mature, secreting vasopressin
neurons. Moreover, further treatment of the re-aggregated cells with SHH induces
efficient differentiation of other types of hypothalamic neurons (Wataya et al. 2008;
Merkle et al. 2015). Very recently, human ESC and iPSC were used to generate
hypothalamic neurons in aggregates (Merkle et al. 2015; Wang et al. 2015), fol-
lowing the previously dribed protocol (Wataya et al. 2008). Hypothalamic neurons
were successfully obtained, but important differences were noted. These included
the requirement for insulin for initial aggregate survival, along with an Akt inhibitor
(Merkle et al. 2015), whereas Wang et al. (2015) used SMAD inhibitors to
inactivate BMP and TGβ/Nodal/Activin pathways to promote neural differenti-
ation. The major types of hypothalamic neurons were obtained, and further cultur-
ing with supporting mouse glia showed that these adopted morphologies similar to
their in vivo counterpart, suggesting a mature phenotype. However there is a large
variability in induction efficiency between experiments (Merkle et al. 2015).
Generation of Hypothalamic Neurons from 2D ESC Cultures
Both Wang et al. (2015) and Merkle et al. (2015) subsequently developed 2D
differentiation protocols to reduce culture duration, providing an easier substrate
for expansion than individual aggregates and also reducing variability in differenti-
ation rate. Human ESC and iPSC were induced toward a hypothalamic progenitor
fate by sequentially performing dual SMAD inhibition while activating ventralizing
SHH signalling (Merkle et al. 2015; Wang et al. 2015). Subsequently, posterior-
izing WNT signals were blocked (Merkle et al. 2015) or the NOTCH pathway was
inhibited (Wang et al. 2015) to induce arcuate-ventral fate. Further culture on
cortical mouse glia supported neuronal differentiation and led to the generation of
the major types of hypothalamic neurons. These showed both the expected morpho-
logy and neuropeptide expression (Merkle et al. 2015), whereas addition of BDNF
induced differentiation of progenitors into functional neurons typical of the arcuate
nucleus. This process was further enhanced by co-culture with mouse astrocytes
(Wang et al. 2015). Neurons were then transplanted into newborn mouse brains.
The human MCH and orexin cells were maintained in the adult where they dis-
played features resembling synapses with mouse neurons, suggesting functional
integration (Merkle et al. 2015).
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Induction of RP from 3D Aggregates
Following their success with generation of hypothalamic-like tissue (Wataya
et al. 2008), Suga et al. (2011) reasoned that, by further inducing rostral character,
they should obtain a domain equivalent to the anterior neural ridge apposed to a
neurectoderm-like tissue, where RP formation may be induced (Ochiai et al. 2015;
see Suga 2016). Large ESC aggregates were made in growth factor-free medium in
the presence of SHH agonist, resulting in formation of a superficial ectodermal
layer surrounding a RAX-positive neurectodermal domain. Subsequently, ecto-
dermal patches thickened, RP marker expression was induced, and invagination
of RP-like structures was observed, more efficiently in the presence of both BMP
and FGF (Ochiai et al. 2015). The positive action of these two factors fits with
in vivo requirements, because these are secreted from the infundibulum and neces-
sary for RP induction and maintenance, respectively (Ericson et al. 1998; Treier
et al. 1998). Inhibition of NOTCH signalling resulted, as reported in vivo (Zhu
et al. 2006; Kita et al. 2007), in efficient differentiation of corticotrophs, one of the
earliest cell types to differentiate. Transplantation of differentiated aggregates
under the kidney capsule in hypophysectomised mice improved cortisol deficiency
symptoms, which demonstrated the functionality of the ESC-derived corticotrophs
(Suga et al. 2011). Obtaining other endocrine cell types was initially less efficient
(Suga et al. 2011); however, addition of BMP and FGF improves both corticotroph
and Pit-1 lineage endocrine cell differentiation (Ochiai et al. 2015).
Induction of placodal identity and differentiation of endocrine cells from 2D
cultures
Human ESC were used to devise a sequential protocol directing cells toward a
placodal fate (Dincer et al. 2013; see Studer 2016). Dual SMAD inhibition was
initially performed to impart neural fate, and subsequent de-repression in combi-
nation with FGF inhibition was sufficient for acquisition of placodal identity.
Modulation of FGF, BMP and SHH pathways further allowed specification of
lens, trigeminal and pituitary placode identity. As shown earlier (Suga
et al. 2011), treatment with an HH agonist induced pituitary placode fate and
subsequently an RP gene expression profile. Corticotroph differentiation followed,
whereas differentiation of somatotrophs and gonadotrophs relied on NOTCH path-
way inhibition. In vivo secretion was demonstrated after sub-cutaneous transplant-
ation in mice (Dincer et al. 2013).
Perspectives
Differentiation Strategies
It takes a minimum of 18 days to observe ACTH-positive cells from ESC aggre-
gates, and maturation of hypothalamic neurons can take much longer (Merkle
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et al. 2015). Moreover, the progression through different developmental stages
implies some degree of heterogeneity in the culture. Finally, and probably in conse-
quence, the percentage of desired cells obtained is often low. For disease modelling,
drug screening and clinical use of these variables should be improved. Culture
conditions can be modified and/or the starting cell type, as we will discuss here.
It has already been observed that co-culture with supporting cells, such as
cortical glia (Merkle et al. 2015) and specifically astrocytes (Wang et al. 2015),
improves differentiation rates of hypothalamic neurons. It has been proposed that
co-culture with neurons may also help (Merkle et al. 2015). Differentiation of
pituitary endocrine cells may similarly be improved by co-culture with folliculo-
stellate cells, a heterogeneous population comprising stem cells but also endocrine-
supporting cells (Allaerts and Vankelecom 2005) and/or endocrine cells. Different
endocrine cell lines exist and one could examine whether co-culture with these
might favor differentiation toward each particular cell type. In addition, generation
of 3D pituitary mixed cell type-aggregates has been described in which tissue-like
organization and endocrine secretions seem to mimic the in vivo situation; more-
over, these characteristics are efficiently maintained over several weeks (Denef
et al. 1989). Co-culture in these conditions may help progenitors to differentiate
more efficiently.
In aggregates, the absence of vascularization may compromise endocrine differ-
entiation and maturation, as observed in organoids, and affect cell survival more
generally in the expanding structures (Lancaster and Knoblich 2014). There are, of
course, many other structural and cellular components of the endogenous stem cell
niche that are missing in these aggregates. Therefore, reconstitution of the stem
cells’ microenvironment in vitro has been the focus of several investigations.
Biomaterials have been developed to support co-culture to supply vascularization,
for example, but also to allow applications of factors, either extracellular matrix or
signalling molecules. Recent and promising droplet-based microfluidic strategies
have been described that can be used in either 3D or 2D cultures (Allazetta and
Lutolf 2015). These in vitro micro-niches are of interest for drug screening because
they are scalable, but they may also offer a suitable substrate to obtain cells for
transplantation. Perhaps these would further allow organization into a pattern
typical of the anterior pituitary.
Starting from pluripotent stem cells, either ESC or iPSC implies a long develop-
mental “journey” to reach a mature terminally differentiated state. Since popu-
lations of progenitors have been characterized in both compartments of the
hypothalamo-pituitary axis, a “short cut” would be to start from somatic cells that
are then directly re-programmed into hypothalamic or pituitary specific stem cells.
Similar protocols were initially described for NSCs (Kim et al. 2011; Ring
et al. 2012; Thier et al. 2012) and many other cell types since. Self-renewal will
be comparable in ESC and iPSC, but the differentiation potential is now limited to
the cells of interest. This implies characterization of the factors necessary and
sufficient to impart the desired identity upon re-programming.
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Implantation in Homotypic Locations
Once the cell types of interest have been efficiently generated in vitro, they can be
transplanted back to restore function. Up to now, transplantations of either pituitary
or hypothalamic ES-derived cells have been realised in heterotopic locations; under
the kidney capsule (Suga et al. 2011), or subcutaneously (Dincer et al. 2013) for
endocrine cells, and in the lateral ventricle or brain parenchyma for hypothalamic
neurons (Merkle et al. 2015).
While Suga et al. (2011) successfully improved some hypophysectomy symp-
toms by implanting cells under the kidney capsule, the pituitary and hypothalamus
are physically and functionally connected: proper regulation of endocrine secre-
tions requires connection with the hypothalamus. In pilot experiments in the 1950s,
Harris and collaborators indeed demonstrated that anterior pituitary transplantation
away from its normal location, such as under the kidney capsule, resulted in chronic
PRL secretion and essentially loss of secretion of the other hormones. In contrast,
grafts implanted near the pituitary stalk, shortly after hypophysiectomy, resulted in
regeneration of the portal system and this was associated with functional integration
of the graft (Harris and Jacobsohn 1951). Therefore, transphenoidal endoscopic cell
transplantation in the human pituitary close to the pituitary stalk should promote
adequate integration and control (see Studer and Tabar 2016).
Hypothalamic neurons need to be able to make relevant connections, particularly
those controlling the pituitary via the ME. Transplantations of cells or grafts have
been realized in the hypothalamus with spectacular results. Placement of pre-optic
area (POA) grafts containing GnRH neurons close to the ME successfully restores
reproductive function in the gnrh1 mutant hypogonadal mice, independently of the
sex of the donor. As expected, success appears to rely on accession of GnRH axons
to the ME (Gibson et al. 1984; Charlton 2004). Anterior hypothalamic implants
comprising the suprachiasmatic nucleus restore periodicity in animals rendered
arrhythmic by hypothalamic lesions (Sollars et al. 1995). More recently, immature
hypothalamic neurons and progenitors were transplanted into the hypothalamic
parenchyma of early postnatal brains of leptin receptor-deficient mice. These
resulted in functional integration and partial restoration of leptin responsiveness
in the adult (Czupryn et al. 2011). However, transplantations close to the ME might
offer better results, because arcuate nucleus grafts transplanted into the third
ventricle, close to the ME, are associated with comparatively better anti-obesity
effects in obese rats (Ono et al. 1990; Fetissov et al. 2000). Integration near a site
where the blood-brain barrier is interrupted might allow access to peripheral
signals, such as leptin in this context and, therefore, better functionality. All these
studies show that hypothalamic implantation can restore function; therefore, they
offer hope that stem cell-derived hypothalamic neurons transplanted near the ME
would be successful. However, as demonstrated in mice, damage to the ME/stalk,
such as that observed after traumatic brain injuries, is probably causative of
pituitary deficiencies (Osterstock et al. 2014). Therefore, just as transplantation
close to this site has been proposed to improve the functionality of both pituitary
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and hypothalamic transplants, care should be taken not to damage this fragile
structure.
Conclusion
The generation of endocrine cells from ESC and their subsequent transplantation
in vivo represent exciting progress towards the use of regenerative medicine to treat
endocrine deficits or manipulate endocrine outputs. Improvement of differentiation
efficiencies and transplantation in homotypic locations should in the near future
demonstrate whether regenerative therapies are suitable for clinical use to treat
neuro-endocrinological disorders.
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